His Cleveland Clinic colleague Leslie Cho, MD, Section Head of Preventive Cardiology, notes that its essential to keep in mind an even broader point that more patients stand to benefit from initiation of GLP-1 receptor agonist therapy of any kind
If you have fever but normal oral intake and no vomiting, continuing tirzepatide is generally safe
For the in vitro experiments, a murine macrophage cell line RAW 264.7 was used
Clues from laboratory models and clinical trials
Month-by-Month Progress: What Research Shows Clinical trials tracking semaglutide show that patients achieve approximately 510% body weight loss by month 3 of treatment, with losses accelerating through months 46
Putur, the patient from the North Shore, said she has struggled with her weight for decades